Neuroscience Markers

Our science-based antibodies and antigens can be a crucial piece of patient diagnostics. While there are still open questions about the clinical value of each marker and practice, step-by-step, we’re solving the diagnostic mystery of neurodegeneration caused by either trauma or diseases.

Together with the newly launched NfL antibodies, we have strengthened our offering on the neurodegeneration diseases. These novelties, side-by-side, with the other neuroscience markers, provide us with new data enabling the use of our markers for assay development and the faster diagnosis of the diseases.

Neuroscience MAbs
already today!
Read more and
order below >>

Trusted Immunological Reagents

Neurofilament light (NfL)
NfL is a neuronal cytoplasmic protein that exists in axons. The concentration of NfL in cerebrospinal fluid (CSF) and blood correlate with the degree of axonal damage.

Beta-amyloid, human
Beta-amyloid, which is also referred to as Aβ, is a peptide that is derived from the amyloid precursor protein. It is one of the most established biomarkers for the progression of Alzheimer’s disease (AD).

Glial fibrillary acidic protein (GFAP)
GFAP is an astrocyte structural protein. GFAP has been authorized as one of the biomarkers for mild traumatic brain injury (mTBI) and its level shows a correlation with the clinical severity after the injury.

S100 proteins
S100 proteins are synthesized in astroglial cells and can be used as sensitive and reliable markers for central nervous system damage.

Cat# 4N6: Neuron-Specific Enolase, Human, antibody


Neuroscience Markers

Monoclonal antibodies

Do you need samples?

We are happy to make you an offer